The role of microneedles for drug and vaccine delivery

Bibliography

• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2012;64:4-17
   Web of Science ®Google Scholar
• Sastry S, Nyshadham J, Fix J. Recent technological advances in oral drug delivery - a review. Pharm Sci Technolo Today 2000;3(4):138-45
   PubMedGoogle Scholar
• Shi Y, Li LC. Current advances in sustained-release systems for parenteral drug delivery. Expert Opin Drug Deliv 2005;2(6):1039-58
   PubMedGoogle Scholar
• Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 2012;64(1):11-29
   PubMed Web of Science ®Google Scholar
• Simonsen L, Kane A, Lloyd J, et al. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999;77(10):789-800
   PubMed Web of Science ®Google Scholar
• Wright S, Yelland M, Heathcote K, et al. Fear of needles-nature and prevalence in general practice. Aust Fam Physician 2009;38(3):172-6
   PubMed Web of Science ®Google Scholar
• Molinuevo JL, Arranz FJ. Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer’s disease. Expert Rev Neurother 2012;12(1):31-7
   PubMed Web of Science ®Google Scholar
• Transdermal Delivery Market Predicted to Reach $31.5 Billion by 2015: PharmaLive Special Report. Pharmaceutical Medical Packaging News. Available from: http://www.pmpnews.com/news/transdermal-delivery-market-predicted-reach-315-billion-2015-pharmalive-special-report 2011 [Last accessed 23 April 2014]
   Google Scholar
• Donnelly RF, Majithiya R, Thakur RRS, et al. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res 2011;28(1):41-57
   PubMed Web of Science ®Google Scholar
• Tuan-Mahmood T-M, McCrudden MTC, Torrisi BM, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci 2013;44(5):623-37
   Google Scholar
• Olatunji O, Das DBD, Garland MJ, et al. Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches. J Pharm Sci 2013;102(4):1209-21
   PubMed Web of Science ®Google Scholar
• Cheung K, Han T, Das DB. Effect of Force of Microneedle Insertion on the Permeability of Insulin in Skin. J Diabetes Sci Technol 2014;8(3):444-52
   PubMedGoogle Scholar
• Donnelly RF, Thakur RRS, Garland MJ, et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater 2012;22(23):4879-90
   PubMed Web of Science ®Google Scholar
• McCrudden MTC, Alkilani AZ, McCrudden CM, et al. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. J Control Release 2014;180:71-80
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012;64(14):1547-68
   PubMed Web of Science ®Google Scholar
• Doddaballapur S. Microneedling with dermaroller. J Cutan Aesthet Surg 2009;2(2):110
   PubMedGoogle Scholar
• Yang SY, O’Cearbhaill ED, Sisk GC, et al. A bio-inspired swellable microneedle adhesive for mechanical interlocking with tissue. Nat Commun 2013;4:1702
   PubMed Web of Science ®Google Scholar
• Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 1998;87(8):922-5
   PubMed Web of Science ®Google Scholar
• McAllister DV, Wang PM, Davis SP, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA 2003;100(24):13755-60
   PubMed Web of Science ®Google Scholar
• Zhou CP, Liu YL, Wang HL, et al. Transdermal delivery of insulin using microneedle rollers in vivo. Int J Pharm 2010;392(1-2):127-33
   PubMed Web of Science ®Google Scholar
• Mikolajewska P, Donnelly RF, Garland MJ, et al. Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema. Pharm Res 2010;27(10):2213-20
   PubMed Web of Science ®Google Scholar
• Stahl J, Wohlert M, Kietzmann M. Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points. BMC Pharmacol Toxicol 2012;13(1):5
   PubMedGoogle Scholar
• Chen J, Qiu Y, Zhang S. Controllable coating of microneedles for transdermal drug delivery. Drug Dev Ind Pharm 2013; Epub ahead of print
   Web of Science ®Google Scholar
• Tas C, Mansoor S, Kalluri H, et al. Delivery of salmon calcitonin using a microneedle patch. Int J Pharm 2012;423(2):257-63
   PubMed Web of Science ®Google Scholar
• Cormier M, Johnson B, Ameri M, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release 2004;97(3):503-11
   PubMed Web of Science ®Google Scholar
• Daddona PE, Matriano JA, Mandema J, Maa Y-F. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res 2011;28(1):159-65
   PubMed Web of Science ®Google Scholar
• Pearton M, Saller V, Coulman SA, et al. Microneedle delivery of plasmid DNA to living human skin: formulation coating, skin insertion and gene expression. J Control Release 2012;160(3):561
   PubMed Web of Science ®Google Scholar
• Chong RHE, Gonzalez-Gonzalez E, Lara MF, et al. Gene silencing following siRNA delivery to skin via coated steel microneedles: in vitro and in vivo proof-of-concept. J Control Release 2013;166(3):211-19
   PubMed Web of Science ®Google Scholar
• Wang P-C, Paik S-J, Kim S-H, Allen MG. Hypodermic-needle-like hollow polymer microneedle array: fabrication and characterization. J Microelectromechanical Syst 2014;1:1-
   Google Scholar
• Martanto W, Moore J, Kashlan O. Microinfusion using ho-llow microneedles. Pharm Res 2006;23(1):104-13
   PubMed Web of Science ®Google Scholar
• Gardeniers HJGE, Luttge R, Berenschot EJW, et al. Silicon micromachined hollow microneedles for transdermal liquid transport. J Microelectromechanical Syst 2003;12(6):855-62
   Web of Science ®Google Scholar
• Garland MJ, Migalska K, Tuan-Mahmood T-M, et al. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays. Int J Pharm 2012;434(1-2):80-9
   PubMedGoogle Scholar
• Gomaa YA, Garland MJM, McInnes F, et al. Laser engineered dissolving microneedles for active transdermal delivery of nadroparin calcium. Int J Pharm 2012;82:299-307
   Google Scholar
• Migalska K, Morrow DIJ, Garland MJ, et al. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res 2011;28(8):1919-30
   PubMed Web of Science ®Google Scholar
• Ito Y, Murano H, Hamasaki N, et al. Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles. Int J Pharm 2011;407(1-2):126-31
   PubMedGoogle Scholar
• Ito Y, Hasegawa R, Fukushima K, et al. Self-dissolving micropile array chip as percutaneous delivery system of protein drug. Biol Pharm Bull 2010;33(4):683-90
   PubMed Web of Science ®Google Scholar
• Lee JW, Choi S-O, Felner EI, Prausnitz MR. Dissolving microneedle patch for transdermal delivery of human growth hormone. Small 2011;7(4):531-9
   PubMed Web of Science ®Google Scholar
• Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008;35(3):193-202
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Moffatt K, Alkilani AZ, et al. Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet. Pharm Res 2014; published online 14 January 2014; doi: 10.1007/s11095-014-1301-y
   Web of Science ®Google Scholar
• Wermeling DP, Banks SL, Hudson DA, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA 2008;105(6-):2058-63
   PubMed Web of Science ®Google Scholar
• Garland MJ, Caffarel-Salvador E, Migalska K, et al. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Release 2012;159(1):52-9
   PubMed Web of Science ®Google Scholar
• Singh ND, Banga AK. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles. J Drug Target 2013;21(4):354-66
   PubMed Web of Science ®Google Scholar
• Kumar V, Banga AK. Modulated iontophoretic delivery of small and large molecules through microchannels. Int J Pharm 2012;434(1-2):106-14
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Garland MJ, Alkilani AZ. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery. Methods Mol Biol 2014;1141:121-32
   PubMedGoogle Scholar
• Han T, Das DB. Permeability enhancement for transdermal delivery of large molecule using low-frequency sonophoresis combined with microneedles. J Pharm Sci 2013;102(10):3614-22
   PubMed Web of Science ®Google Scholar
• Gupta J, Gill HS, Andrews SN, Prausnitz MR. Kinetics of skin resealing after insertion of microneedles in human subjects. J Control Release 2011;154(2):148-55
   PubMed Web of Science ®Google Scholar
• Yan G, Arelly N, Farhan N, et al. Enhancing DNA delivery into the skin with a motorized microneedle device. Eur J Pharm Sci 2014;52:215-22
   PubMed Web of Science ®Google Scholar
• Zhang D, Das DB, Rielly CD. Potential of microneedle-assisted micro-particle delivery by gene guns: a review. Drug Deliv 2013; [Epub ahead of print]
   Web of Science ®Google Scholar
• Vučen SR, Vuleta G, Crean AM, et al. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles. J Pharm Pharmacol 2013;65(10):1451-62
   PubMed Web of Science ®Google Scholar
• Qiu Y, Gao Y, Hu K, Li F. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release 2008;129(2):144-50
   PubMed Web of Science ®Google Scholar
• Hegde NR, Kaveri S V, Bayry J. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination. Drug Discov Today 2011;16(23-24):1061-8
   PubMed Web of Science ®Google Scholar
• Al-Zahrani S, Zaric M, McCrudden C, et al. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv 2012;9(5):541-50
   PubMed Web of Science ®Google Scholar
• Combadière B, Vogt A, Mahé B, et al. Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One 2010;5(5):e10818
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Baudner BC, Oh S, et al. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci 2012;101(3):1021-7
   PubMed Web of Science ®Google Scholar
• Raphael AP, Prow TW, Crichton ML, et al. Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small 2010;6(16):1785-93
   PubMed Web of Science ®Google Scholar
• Sullivan SP, Koutsonanos DG, Del Pilar Martin M, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 2010;16(8):915-20
   PubMed Web of Science ®Google Scholar
• Zaric M, Lyubomska O, Touzelet O, et al. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano 2013;7(3):2042-55
   PubMed Web of Science ®Google Scholar
• Matsuo K, Hirobe S, Yokota Y, et al. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. J Control Release 2012;160(3):495-501
   PubMed Web of Science ®Google Scholar
• Matsuo K, Okamoto H, Kawai Y, et al. Vaccine efficacy of transcutaneous immunization with amyloid beta using a dissolving microneedle array in a mouse model of Alzheimer’s disease. J Neuroimmunol 2014;266(1-2):1-11
   PubMed Web of Science ®Google Scholar
• McGrath MG, Vrdoljak A, O’Mahony C, et al. Determination of parameters for successful spray coating of silicon microneedle arrays. Int J Pharm 2011;415(1-2):140-9
   PubMed Web of Science ®Google Scholar
• Weldon WC, Zarnitsyn VG, Esser ES, et al. Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine. PLoS One 2012;7(7):e41501
   PubMed Web of Science ®Google Scholar
• Choi HJ, Bondy BJ, Yoo DG, et al. Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. J Control Release 2013;166(2):159-71
   PubMed Web of Science ®Google Scholar
• Chen X, Fernando GJP, Raphael AP, et al. Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin. J Control Release 2012;158(1):78-84
   PubMed Web of Science ®Google Scholar
• Edens C, Collins ML, Ayers J, et al. Measles vaccination using a microneedle patch. Vaccine 2013;31(34):3403-9
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Baudner BC, Bonificio A, et al. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine 2013;31(34):3435-41
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zarnitsyn VG, Ye L, et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci USA 2009;106(19):7968-73
   PubMed Web of Science ®Google Scholar
• Wang B-Z, Gill HS, He C, et al. Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity. J Control Release 2014;178:1-7
   PubMed Web of Science ®Google Scholar
• Vrdoljak A, McGrath MG, Carey JB, et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release 2012;159(1):34-42
   PubMed Web of Science ®Google Scholar
• Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 2012;11(2):189-209
   PubMed Web of Science ®Google Scholar
• DeMuth PC, Moon JJ, Suh H, et al. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. ACS Nano 2012;6(9):8041-51
   PubMed Web of Science ®Google Scholar
• Kim NW, Lee MS, Kim KR, et al. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine. J Control Release 2014;179:11-17
   PubMed Web of Science ®Google Scholar
• Burton SA, Ng CY, Simmers R, et al. Rapid intradermal delivery of liquid formulations using a hollow microstructured array. Pharm Res 2011;28(1):31-40
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bonnet S, Alchas P, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007;25(52):8833-42
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Dekker JP, Harvey NG, et al. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 2006;74(12):6806-10
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bourhy H, Fantino M, et al. Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine 2010;28(36):5850-6
   PubMed Web of Science ®Google Scholar
• Morefield GL, Tammariello RF, Purcell BK, et al. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock. J Immune Based Ther Vaccines 2008;6(1):5
   PubMedGoogle Scholar
• Kim YC, Quan FS, Compans RW, et al. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release 2010;142(2):187-95
   PubMed Web of Science ®Google Scholar
• Lee BY, Cakouros BE, Assi T-M, et al. The impact of making vaccines thermostable in Niger’s vaccine supply chain. Vaccine 2012;30(38):5637-43
   PubMed Web of Science ®Google Scholar
• Rattanapak T, Birchall JC, Young K, et al. Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization. PLoS ONE 2014;9(2):e89503
   PubMedGoogle Scholar
• Beran J, Ambrozaitis A, Laiskonis A, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009;7:13
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009;27(52):7304-12
   PubMed Web of Science ®Google Scholar
• Ogden S, Dearman RJ, Kimber I, Griffiths CEM. The effect of ageing on phenotype and function of monocyte-derived Langerhans cells. Br J Dermatol 2011;165(1):184-8
   PubMed Web of Science ®Google Scholar
• Brogden NK, Banks SL, Crofford LJ, Stinchcomb AL. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans. Pharm Res 2013;30(8):1947-55
   PubMed Web of Science ®Google Scholar
• Ghosh P, Brogden NK, Stinchcomb AL. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin. J Pharm Sci 2014;103(2):652-60
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Mooney K, McCrudden MTC, et al. Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected. J Pharm Sci 2014;103(5):1478-86
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Thakur RRS, Alkilani AZ, et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. Int J Pharm 2013;451(1-2):76-91
   PubMed Web of Science ®Google Scholar
• Haq MI, Smith E, John DN, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 2009;11(1):35-47
   PubMed Web of Science ®Google Scholar
• Gill HS, Denson DD, Burris BA. Effect of microneedle design on pain in human volunteers. Clin J Pain 2008;24(7):585-94
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Thakur RRS, Tunney MM, et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 2009;26(11):2513-22
   PubMed Web of Science ®Google Scholar
• Li W-Z, Huo M-R, Zhou J-P, et al. Super-short solid silicon microneedles for transdermal drug delivery applications. Int J Pharm 2010;389(1-2):122-9
   PubMedGoogle Scholar
• Soltani-Arabshahi R, Wong JW, Duffy KL, Powell DL. Facial allergic granulomatous reaction and systemic hypersensitivity associated with microneedle therapy for skin rejuvenation. JAMA Dermatol 2014;150(1):68-72
   PubMed Web of Science ®Google Scholar
• Birchall JC, Clemo R, Anstey A, John DN. Microneedles in clinical practice--an exploratory study into the opinions of healthcare professionals and the public. Pharm Res 2011;28(1):95-106
   PubMed Web of Science ®Google Scholar
• Mooney K, McElnay JC, Donnelly RF. Children’s views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract 2013; [Epub ahead of print]
   PubMedGoogle Scholar
• Norman JJ, Brown MR, Raviele NA, et al. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes. Pediatr Diabetes 2013;14(6):459-65
   PubMed Web of Science ®Google Scholar
• Declining Medicine Use and Costs: for Better or Worse? A Review of the Use of Medicines in the United States in 2012. IMS Institute for Healthcare Informatics. 2013. Available from: http://static.correofarmaceutico.com/docs/2013/05/20/usareport.pdf [Last accessed 23 April 2014]
   Google Scholar
• Norman JJ, Arya JM, McClain MA, et al. Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine 2014;32(16):1856-62
   PubMed Web of Science ®Google Scholar
• Del Pilar Martin M, Weldon W, Zarnitsyn V, et al. Local response to microneedle-based influenza immunization in the skin. MBio 2012;3(2):e00012-12
   PubMed Web of Science ®Google Scholar
• Draft Guidance for Industry and Food and Drug Administration Staffâ: Applying Human Factors and Usability Engineering to Optimize Medical Device Design. FDA. CDRH, Office of Device Evaluation, Washington, DC; 2011. Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM259760.pdf [Last accessed 23 April 2014]
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-97
   PubMed Web of Science ®Google Scholar
• Carey JB, Pearson FE, Vrdoljak A, et al. Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice. PLoS One 2011;6(7):e22442
   PubMed Web of Science ®Google Scholar